GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » Cyclically Adjusted FCF per Share

Daiichinkyo Co (TSE:4568) Cyclically Adjusted FCF per Share : 円63.30 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Daiichinkyo Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was 円-9.073. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is 円63.30 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Daiichinkyo Co's average Cyclically Adjusted FCF Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Daiichinkyo Co was 4.50% per year. The lowest was 1.00% per year. And the median was 1.55% per year.

As of today (2024-04-27), Daiichinkyo Co's current stock price is 円5010.00. Daiichinkyo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was 円63.30. Daiichinkyo Co's Cyclically Adjusted Price-to-FCF of today is 79.15.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Daiichinkyo Co was 135.66. The lowest was 21.98. And the median was 67.50.


Daiichinkyo Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Daiichinkyo Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Cyclically Adjusted FCF per Share Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.02 37.58 37.43 37.23 63.30

Daiichinkyo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.23 33.54 34.55 66.36 63.30

Competitive Comparison of Daiichinkyo Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Cyclically Adjusted Price-to-FCF falls into.



Daiichinkyo Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiichinkyo Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-9.073/107.2000*107.2000
=-9.073

Current CPI (Mar. 2024) = 107.2000.

Daiichinkyo Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 2.209 98.000 2.416
201409 6.434 98.500 7.002
201412 9.779 97.900 10.708
201503 4.328 97.900 4.739
201506 -3.928 98.400 -4.279
201509 12.375 98.500 13.468
201512 8.179 98.100 8.938
201603 31.012 97.900 33.958
201606 12.651 98.100 13.825
201609 11.058 98.000 12.096
201612 -2.706 98.400 -2.948
201703 20.179 98.100 22.051
201706 -4.948 98.500 -5.385
201709 6.415 98.800 6.960
201712 7.675 99.400 8.277
201803 26.619 99.200 28.766
201806 -12.415 99.200 -13.416
201809 3.144 99.900 3.374
201812 2.125 99.700 2.285
201903 20.196 99.700 21.715
201906 32.879 99.800 35.317
201909 6.742 100.100 7.220
201912 10.849 100.500 11.572
202003 23.479 100.300 25.094
202006 8.667 99.900 9.300
202009 24.812 99.900 26.625
202012 6.613 99.300 7.139
202103 25.964 99.900 27.861
202106 -27.463 99.500 -29.588
202109 22.155 100.100 23.726
202112 26.810 100.100 28.712
202203 11.097 101.100 11.767
202206 -21.238 101.800 -22.365
202209 28.063 103.100 29.179
202212 9.614 104.100 9.900
202303 8.135 104.400 8.353
202306 -37.915 105.200 -38.636
202309 -21.311 106.200 -21.512
202312 316.630 106.800 317.816
202403 -9.073 107.200 -9.073

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Daiichinkyo Co  (TSE:4568) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Daiichinkyo Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=5010.00/63.3
=79.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Daiichinkyo Co was 135.66. The lowest was 21.98. And the median was 67.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Daiichinkyo Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co (TSE:4568) Business Description

Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (TSE:4568) Headlines

No Headlines